Gene Symbol | Gene ID | Gene Info |
---|---|---|
Yy1
|
ENSMUSG00000021264.11 | YY1 transcription factor |
Yy2
|
ENSMUSG00000091736.2 | Yy2 transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_108795266_108795434 | Yy1 | 2377 | 0.158218 | -0.43 | 1.2e-03 | Click! |
chr12_108794058_108794786 | Yy1 | 1449 | 0.229957 | -0.41 | 1.9e-03 | Click! |
chr12_108794953_108795141 | Yy1 | 2074 | 0.173535 | -0.30 | 2.4e-02 | Click! |
chr12_108793311_108793525 | Yy1 | 445 | 0.539501 | -0.24 | 7.2e-02 | Click! |
chr12_108793756_108794039 | Yy1 | 924 | 0.334893 | -0.10 | 4.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 56.01 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr7_6727792_6729098 | 40.25 |
Peg3 |
paternally expressed 3 |
1974 |
0.16 |
chr2_173658978_173659962 | 36.68 |
Ppp4r1l-ps |
protein phosphatase 4, regulatory subunit 1-like, pseudogene |
34 |
0.8 |
chr19_61225302_61226760 | 34.47 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr3_139885937_139886924 | 33.26 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr10_81364518_81366962 | 32.81 |
4930404N11Rik |
RIKEN cDNA 4930404N11 gene |
50 |
0.91 |
chr7_6729309_6729829 | 31.69 |
Peg3 |
paternally expressed 3 |
850 |
0.28 |
chr14_14350947_14351733 | 31.02 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr3_82406341_82406796 | 29.17 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr2_49672278_49672906 | 28.12 |
Gm13525 |
predicted gene 13525 |
7907 |
0.24 |
chr9_124439906_124440949 | 26.39 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr9_8900765_8902148 | 25.99 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr14_24617341_24617911 | 25.95 |
4930428N03Rik |
RIKEN cDNA 4930428N03 gene |
58 |
0.64 |
chr3_88222441_88222775 | 25.03 |
Gm3764 |
predicted gene 3764 |
56 |
0.93 |
chr17_27203606_27204996 | 24.30 |
Lemd2 |
LEM domain containing 2 |
168 |
0.9 |
chr1_34583668_34584368 | 22.81 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
4307 |
0.1 |
chr8_54992339_54992525 | 22.69 |
Gm45265 |
predicted gene 45265 |
12853 |
0.14 |
chr8_70476397_70477967 | 22.48 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr5_104109996_104110359 | 22.09 |
Gm26703 |
predicted gene, 26703 |
886 |
0.46 |
chr4_81567754_81568245 | 21.46 |
Gm11765 |
predicted gene 11765 |
106267 |
0.07 |
chr13_105444197_105444941 | 21.41 |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A |
930 |
0.71 |
chr8_70129255_70130053 | 21.41 |
Nr2c2ap |
nuclear receptor 2C2-associated protein |
1679 |
0.17 |
chr12_103324974_103325864 | 21.30 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
10165 |
0.11 |
chr1_88254702_88255947 | 20.84 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr15_40169638_40170055 | 20.37 |
Gm33301 |
predicted gene, 33301 |
7239 |
0.19 |
chr2_132427639_132427949 | 20.27 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr5_60600153_60600339 | 20.14 |
Gm43390 |
predicted gene 43390 |
21616 |
0.23 |
chr10_43023952_43024111 | 19.97 |
Gm47815 |
predicted gene, 47815 |
10962 |
0.22 |
chr6_18446901_18447365 | 19.94 |
Gm26233 |
predicted gene, 26233 |
2207 |
0.27 |
chr11_34276626_34277049 | 19.91 |
4930403D09Rik |
RIKEN cDNA 4930403D09 gene |
22870 |
0.17 |
chr4_31366167_31366509 | 19.81 |
Gm11922 |
predicted gene 11922 |
14134 |
0.31 |
chr7_44405306_44405805 | 19.79 |
Gm45124 |
predicted gene 45124 |
19155 |
0.06 |
chr17_9726102_9726458 | 19.23 |
Gm34684 |
predicted gene, 34684 |
73 |
0.98 |
chr9_37359459_37360109 | 19.15 |
Hepacam |
hepatocyte cell adhesion molecule |
7567 |
0.11 |
chr3_66326110_66326323 | 19.03 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
29379 |
0.18 |
chr3_68072068_68072422 | 18.99 |
Schip1 |
schwannomin interacting protein 1 |
7443 |
0.3 |
chr9_43699339_43700154 | 18.90 |
Gm5364 |
predicted gene 5364 |
16693 |
0.14 |
chr10_81176405_81177305 | 18.77 |
Eef2 |
eukaryotic translation elongation factor 2 |
224 |
0.79 |
chr11_12231499_12232054 | 18.75 |
Gm12002 |
predicted gene 12002 |
82738 |
0.09 |
chr18_14320236_14320668 | 18.73 |
Gm29992 |
predicted gene, 29992 |
10824 |
0.18 |
chr15_36967359_36968246 | 18.65 |
Gm34590 |
predicted gene, 34590 |
28938 |
0.13 |
chr14_14345884_14346978 | 18.52 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr13_26656976_26657325 | 18.47 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr8_94994579_94995017 | 18.46 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
37 |
0.96 |
chr16_63806861_63807216 | 18.44 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr17_12289940_12290395 | 18.12 |
Gm49962 |
predicted gene, 49962 |
10050 |
0.13 |
chr6_114289060_114289436 | 17.96 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
6458 |
0.27 |
chr5_109556763_109557843 | 17.96 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr9_99112541_99112867 | 17.94 |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
27221 |
0.15 |
chr12_99010963_99011149 | 17.86 |
Gm47109 |
predicted gene, 47109 |
18047 |
0.16 |
chr2_105674521_105675719 | 17.78 |
Pax6 |
paired box 6 |
11 |
0.97 |
chr14_102926123_102926411 | 17.64 |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
55284 |
0.1 |
chr8_69161317_69161515 | 17.62 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
20463 |
0.15 |
chr13_78194795_78195669 | 17.53 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1141 |
0.38 |
chr1_85089758_85090158 | 17.30 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr8_4206127_4207837 | 17.28 |
4932443L11Rik |
RIKEN cDNA 4932443L11 gene |
100 |
0.88 |
chr11_98284318_98284581 | 17.27 |
Gm20644 |
predicted gene 20644 |
933 |
0.39 |
chr13_55362078_55363351 | 17.18 |
Lman2 |
lectin, mannose-binding 2 |
69 |
0.95 |
chr9_110053315_110053992 | 17.14 |
Map4 |
microtubule-associated protein 4 |
1601 |
0.28 |
chr10_59090146_59090665 | 17.13 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
10371 |
0.24 |
chr8_41054736_41055125 | 17.08 |
Mtus1 |
mitochondrial tumor suppressor 1 |
136 |
0.94 |
chr11_117478577_117478870 | 17.00 |
Gm34418 |
predicted gene, 34418 |
3874 |
0.18 |
chr4_120242723_120243628 | 16.84 |
Foxo6 |
forkhead box O6 |
44174 |
0.14 |
chr5_78622542_78622942 | 16.83 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chr16_84834492_84835156 | 16.76 |
Atp5j |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F |
8 |
0.58 |
chr5_84153090_84153587 | 16.74 |
Hmgn2-ps1 |
high mobility group nucleosomal binding domain 2, pseudogene 1 |
30025 |
0.25 |
chr2_61815550_61816375 | 16.35 |
Tbr1 |
T-box brain gene 1 |
9689 |
0.18 |
chr5_129724468_129725740 | 16.30 |
Nipsnap2 |
nipsnap homolog 2 |
3 |
0.95 |
chr14_48907500_48907651 | 16.29 |
Gm534 |
predicted gene 534 |
25706 |
0.13 |
chr2_10079825_10080668 | 16.22 |
Atp5c1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 |
70 |
0.8 |
chr14_55054973_55055741 | 16.17 |
Gm20687 |
predicted gene 20687 |
136 |
0.88 |
chr5_139344125_139345335 | 16.12 |
Cox19 |
cytochrome c oxidase assembly protein 19 |
395 |
0.77 |
chr13_19622971_19623817 | 16.11 |
Sfrp4 |
secreted frizzled-related protein 4 |
219 |
0.92 |
chr9_13246797_13247848 | 16.08 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr5_131794610_131795069 | 16.05 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
85430 |
0.06 |
chr4_100945474_100945811 | 15.99 |
Cachd1 |
cache domain containing 1 |
48969 |
0.14 |
chr7_64048550_64049610 | 15.97 |
Gm45054 |
predicted gene 45054 |
8254 |
0.16 |
chr7_96474512_96474810 | 15.96 |
Rps11-ps5 |
ribosomal protein S11, pseudogene 5 |
38644 |
0.17 |
chr13_48966851_48968700 | 15.88 |
Fam120a |
family with sequence similarity 120, member A |
242 |
0.95 |
chr13_99516425_99517155 | 15.88 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr5_37028014_37028420 | 15.84 |
Jakmip1 |
janus kinase and microtubule interacting protein 1 |
118 |
0.96 |
chr1_34665920_34666140 | 15.71 |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
12158 |
0.12 |
chr10_81383963_81384933 | 15.68 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
11 |
0.48 |
chr7_29071715_29071901 | 15.62 |
Gm26604 |
predicted gene, 26604 |
171 |
0.61 |
chr4_4380341_4380585 | 15.50 |
Gm11780 |
predicted gene 11780 |
148256 |
0.04 |
chr3_69709128_69709981 | 15.49 |
Rpl32-ps |
ribosomal protein L32, pseudogene |
7839 |
0.17 |
chr6_119329664_119330446 | 15.47 |
Lrtm2 |
leucine-rich repeats and transmembrane domains 2 |
702 |
0.44 |
chrX_134807856_134808471 | 15.45 |
Armcx2 |
armadillo repeat containing, X-linked 2 |
221 |
0.9 |
chr7_51625279_51625512 | 15.43 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
247 |
0.93 |
chr7_60003092_60003312 | 15.41 |
Snurf |
SNRPN upstream reading frame |
1847 |
0.13 |
chr16_18400546_18401147 | 15.39 |
Arvcf |
armadillo repeat gene deleted in velocardiofacial syndrome |
286 |
0.82 |
chr4_100973634_100974412 | 15.36 |
Cachd1 |
cache domain containing 1 |
20588 |
0.19 |
chr18_42644502_42645243 | 15.35 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
22413 |
0.16 |
chr13_54874229_54874840 | 15.31 |
Gm29431 |
predicted gene 29431 |
12936 |
0.13 |
chr5_33935744_33936902 | 15.30 |
Nelfa |
negative elongation factor complex member A, Whsc2 |
73 |
0.95 |
chr10_56115250_56115679 | 15.29 |
Msl3l2 |
MSL3 like 2 |
549 |
0.8 |
chr1_169462517_169462741 | 15.27 |
Gm5265 |
predicted pseudogene 5265 |
8760 |
0.25 |
chr6_134887759_134888112 | 15.16 |
Gpr19 |
G protein-coupled receptor 19 |
103 |
0.94 |
chr12_29527021_29527799 | 15.01 |
Myt1l |
myelin transcription factor 1-like |
974 |
0.61 |
chr5_100108777_100109262 | 15.01 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr3_39209382_39209730 | 14.98 |
Gm43008 |
predicted gene 43008 |
8290 |
0.29 |
chr4_92542214_92542447 | 14.96 |
Gm12637 |
predicted gene 12637 |
13779 |
0.3 |
chr12_102554973_102555665 | 14.83 |
Chga |
chromogranin A |
333 |
0.86 |
chr8_71908248_71908670 | 14.80 |
Zfp882 |
zinc finger protein 882 |
149 |
0.52 |
chr10_80741710_80742767 | 14.59 |
Ap3d1 |
adaptor-related protein complex 3, delta 1 subunit |
26 |
0.95 |
chr8_25465368_25465990 | 14.49 |
Gm10689 |
predicted gene 10689 |
11406 |
0.11 |
chr16_34395456_34395879 | 14.48 |
Kalrn |
kalirin, RhoGEF kinase |
3558 |
0.38 |
chr7_64696356_64696507 | 14.41 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
32971 |
0.2 |
chr5_37245988_37246869 | 14.37 |
Crmp1 |
collapsin response mediator protein 1 |
583 |
0.76 |
chr6_50776731_50777167 | 14.37 |
C530044C16Rik |
RIKEN cDNA C530044C16 gene |
625 |
0.69 |
chr2_66041591_66042392 | 14.37 |
Galnt3 |
polypeptide N-acetylgalactosaminyltransferase 3 |
52080 |
0.12 |
chr7_30291145_30292058 | 14.31 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr8_9771269_9772260 | 14.27 |
Fam155a |
family with sequence similarity 155, member A |
603 |
0.53 |
chr9_49624454_49624605 | 14.21 |
Ncam1 |
neural cell adhesion molecule 1 |
55980 |
0.15 |
chr15_86419577_86420037 | 14.20 |
A930001M01Rik |
RIKEN cDNA A930001M01 gene |
55288 |
0.15 |
chr5_73647229_73648112 | 14.19 |
Gm43799 |
predicted gene 43799 |
79 |
0.55 |
chr18_76533404_76533599 | 14.15 |
Gm31933 |
predicted gene, 31933 |
99369 |
0.08 |
chr16_57121584_57122223 | 14.15 |
Tomm70a |
translocase of outer mitochondrial membrane 70A |
200 |
0.94 |
chr17_45548642_45549512 | 14.08 |
Tmem151b |
transmembrane protein 151B |
600 |
0.55 |
chr3_32817066_32817811 | 14.08 |
Usp13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
108 |
0.97 |
chr9_102212054_102212331 | 13.98 |
Gm37945 |
predicted gene, 37945 |
39454 |
0.13 |
chr3_87973849_87975045 | 13.98 |
Nes |
nestin |
3318 |
0.12 |
chr11_104158535_104158753 | 13.93 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
25789 |
0.16 |
chr11_97449609_97450728 | 13.90 |
Arhgap23 |
Rho GTPase activating protein 23 |
8 |
0.97 |
chr11_118793598_118794019 | 13.87 |
Gm11750 |
predicted gene 11750 |
2436 |
0.3 |
chr12_45466153_45466321 | 13.86 |
Gm33680 |
predicted gene, 33680 |
36 |
0.98 |
chr9_34485973_34486388 | 13.85 |
Kirrel3 |
kirre like nephrin family adhesion molecule 3 |
54 |
0.98 |
chr2_174472333_174473544 | 13.81 |
Prelid3b |
PRELI domain containing 3B |
4 |
0.96 |
chrX_103186116_103186278 | 13.77 |
Nap1l2 |
nucleosome assembly protein 1-like 2 |
443 |
0.75 |
chr11_28583310_28583938 | 13.76 |
Ccdc85a |
coiled-coil domain containing 85A |
371 |
0.91 |
chr12_3364588_3366025 | 13.70 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chrX_52987953_52988778 | 13.65 |
Hprt |
hypoxanthine guanine phosphoribosyl transferase |
228 |
0.89 |
chr16_16559483_16559649 | 13.61 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
424 |
0.84 |
chr2_73385763_73387080 | 13.59 |
Gpr155 |
G protein-coupled receptor 155 |
9 |
0.9 |
chr14_55053693_55054126 | 13.55 |
Zfhx2os |
zinc finger homeobox 2, opposite strand |
38 |
0.92 |
chr14_63756121_63756555 | 13.49 |
Mir598 |
microRNA 598 |
29149 |
0.17 |
chr18_43619433_43619779 | 13.47 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
45361 |
0.14 |
chr18_23522000_23522220 | 13.46 |
Dtna |
dystrobrevin alpha |
10649 |
0.29 |
chr6_113194087_113194434 | 13.46 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
317 |
0.86 |
chrX_53716337_53717049 | 13.43 |
AW822252 |
expressed sequence AW822252 |
79 |
0.95 |
chr2_136713383_136713943 | 13.33 |
Snap25 |
synaptosomal-associated protein 25 |
185 |
0.95 |
chr7_79531698_79531891 | 13.32 |
Mir9-3hg |
Mir9-3 host gene |
3944 |
0.11 |
chr5_97195267_97195639 | 13.28 |
Gm2861 |
predicted gene 2861 |
133 |
0.97 |
chr3_138784229_138784607 | 13.28 |
Tspan5 |
tetraspanin 5 |
1564 |
0.42 |
chr10_78464271_78465733 | 13.22 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr12_111758304_111760062 | 13.22 |
Klc1 |
kinesin light chain 1 |
170 |
0.91 |
chr4_82705266_82705715 | 13.18 |
Nfib |
nuclear factor I/B |
260 |
0.93 |
chr6_51592327_51592791 | 13.14 |
Gm22914 |
predicted gene, 22914 |
29073 |
0.18 |
chr6_103944408_103944702 | 13.14 |
Gm21054 |
predicted gene, 21054 |
20084 |
0.27 |
chr2_101172759_101173110 | 13.13 |
Gm20693 |
predicted gene 20693 |
397690 |
0.01 |
chr15_103519338_103519794 | 13.13 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
4152 |
0.16 |
chr7_4120579_4121016 | 13.12 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
69 |
0.88 |
chr13_83727942_83728228 | 13.10 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
21 |
0.96 |
chr8_71670876_71671939 | 13.08 |
Unc13a |
unc-13 homolog A |
329 |
0.75 |
chr7_44442436_44442849 | 13.01 |
Lrrc4b |
leucine rich repeat containing 4B |
95 |
0.92 |
chr7_67421434_67421985 | 13.00 |
Gm33926 |
predicted gene, 33926 |
22224 |
0.17 |
chr3_66325480_66326023 | 12.97 |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
28914 |
0.18 |
chr9_43071086_43071495 | 12.95 |
Arhgef12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
28658 |
0.16 |
chr1_93101519_93102308 | 12.94 |
Kif1a |
kinesin family member 1A |
38 |
0.97 |
chr14_34969154_34969501 | 12.93 |
Mir346 |
microRNA 346 |
74718 |
0.11 |
chr7_92874762_92875359 | 12.88 |
Prcp |
prolylcarboxypeptidase (angiotensinase C) |
192 |
0.86 |
chr2_74426718_74427115 | 12.85 |
Lnpk |
lunapark, ER junction formation factor |
106190 |
0.05 |
chr1_92680883_92681479 | 12.83 |
Otos |
otospiralin |
32340 |
0.09 |
chr5_9339220_9339538 | 12.83 |
Gm15733 |
predicted gene 15733 |
14380 |
0.19 |
chr12_29663403_29663734 | 12.81 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
22877 |
0.25 |
chrX_167654944_167655095 | 12.80 |
Gm15238 |
predicted gene 15238 |
121242 |
0.06 |
chr3_88239048_88239748 | 12.80 |
Gm3764 |
predicted gene 3764 |
10615 |
0.07 |
chr3_103401351_103401502 | 12.79 |
Gm25009 |
predicted gene, 25009 |
8493 |
0.17 |
chr1_136142237_136142876 | 12.76 |
Kif21b |
kinesin family member 21B |
11102 |
0.11 |
chr4_104269884_104270083 | 12.73 |
Dab1 |
disabled 1 |
97130 |
0.09 |
chr2_25125625_25126488 | 12.65 |
AL732309.1 |
exonuclease 3'-5' domain containing 3 (EXD3) pseudogene |
9775 |
0.08 |
chr1_79450325_79450959 | 12.64 |
Scg2 |
secretogranin II |
10522 |
0.24 |
chr14_66494473_66494955 | 12.62 |
Gm23899 |
predicted gene, 23899 |
96981 |
0.07 |
chr13_39571511_39571701 | 12.58 |
Gm47352 |
predicted gene, 47352 |
23 |
0.98 |
chr17_42603446_42603756 | 12.58 |
Opn5 |
opsin 5 |
7794 |
0.28 |
chr16_63501537_63501741 | 12.56 |
Gm49622 |
predicted gene, 49622 |
9522 |
0.32 |
chr12_29882839_29883206 | 12.53 |
Myt1l |
myelin transcription factor 1-like |
12092 |
0.26 |
chr7_45361179_45361983 | 12.51 |
Ppfia3 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
241 |
0.77 |
chr3_16854034_16854185 | 12.48 |
Gm26485 |
predicted gene, 26485 |
30797 |
0.26 |
chr8_83901641_83902225 | 12.46 |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
1198 |
0.33 |
chr1_39947591_39947985 | 12.44 |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
16367 |
0.22 |
chr9_72766796_72767311 | 12.44 |
Gm27204 |
predicted gene 27204 |
9172 |
0.12 |
chrX_53607803_53608436 | 12.41 |
Rtl8c |
retrotransposon Gag like 8C |
87 |
0.92 |
chr11_112817897_112818851 | 12.41 |
4933434M16Rik |
RIKEN cDNA 4933434M16 gene |
6780 |
0.2 |
chr18_25533471_25533781 | 12.40 |
Celf4 |
CUGBP, Elav-like family member 4 |
32387 |
0.21 |
chr3_158559650_158560260 | 12.39 |
Lrrc7 |
leucine rich repeat containing 7 |
1381 |
0.57 |
chr9_106464770_106466154 | 12.37 |
Gpr62 |
G protein-coupled receptor 62 |
476 |
0.6 |
chr8_33992574_33993302 | 12.34 |
Gm45817 |
predicted gene 45817 |
5738 |
0.17 |
chr19_21742139_21742471 | 12.33 |
Gm50129 |
predicted gene, 50129 |
13035 |
0.2 |
chr14_19920192_19920714 | 12.32 |
Gm48283 |
predicted gene, 48283 |
53473 |
0.1 |
chr3_94477953_94478530 | 12.32 |
Celf3 |
CUGBP, Elav-like family member 3 |
54 |
0.93 |
chr8_70905797_70906132 | 12.31 |
Map1s |
microtubule-associated protein 1S |
18 |
0.94 |
chr14_5000842_5001422 | 12.29 |
Gm3298 |
predicted gene 3298 |
14759 |
0.13 |
chr16_44687184_44688343 | 12.29 |
Nepro |
nucleolus and neural progenitor protein |
36538 |
0.14 |
chr17_88316794_88316983 | 12.27 |
1700116H05Rik |
RIKEN cDNA 1700116H05 gene |
10001 |
0.19 |
chr2_153425549_153426538 | 12.26 |
Gm14472 |
predicted gene 14472 |
12194 |
0.16 |
chr8_84459359_84459561 | 12.25 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
43676 |
0.12 |
chr9_96732055_96732515 | 12.25 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
384 |
0.84 |
chr14_55029006_55029605 | 12.23 |
Ngdn |
neuroguidin, EIF4E binding protein |
7883 |
0.07 |
chr7_79519799_79520848 | 12.22 |
Gm37608 |
predicted gene, 37608 |
3441 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.4 | 73.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
12.3 | 36.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
11.9 | 47.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
11.8 | 35.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
9.7 | 48.4 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
9.5 | 28.5 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
9.0 | 27.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
8.3 | 8.3 | GO:0061642 | chemoattraction of axon(GO:0061642) |
8.2 | 24.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
7.7 | 23.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
7.5 | 30.0 | GO:0007412 | axon target recognition(GO:0007412) |
7.3 | 22.0 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
7.3 | 58.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
7.1 | 28.5 | GO:0060486 | Clara cell differentiation(GO:0060486) |
7.1 | 21.4 | GO:0030070 | insulin processing(GO:0030070) |
7.0 | 21.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
7.0 | 21.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
7.0 | 20.9 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
6.9 | 6.9 | GO:0021550 | medulla oblongata development(GO:0021550) |
6.9 | 20.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
6.8 | 20.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
6.8 | 33.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
6.8 | 20.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
6.6 | 13.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
6.6 | 46.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
6.5 | 26.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
6.4 | 38.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
6.4 | 19.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
6.3 | 6.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
6.3 | 18.9 | GO:0021564 | vagus nerve development(GO:0021564) |
6.2 | 6.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
6.1 | 18.2 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
6.0 | 17.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
6.0 | 41.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
5.8 | 17.3 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
5.7 | 11.5 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
5.7 | 17.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
5.7 | 17.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
5.7 | 17.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.7 | 22.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
5.6 | 16.8 | GO:0046684 | response to pyrethroid(GO:0046684) |
5.5 | 5.5 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
5.5 | 11.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
5.3 | 21.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
5.3 | 21.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
5.3 | 26.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
5.1 | 15.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
5.1 | 25.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.1 | 10.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
5.1 | 56.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
5.1 | 25.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
5.0 | 20.0 | GO:0061743 | motor learning(GO:0061743) |
5.0 | 39.9 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
5.0 | 15.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
5.0 | 19.9 | GO:0030035 | microspike assembly(GO:0030035) |
5.0 | 19.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.9 | 4.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
4.9 | 14.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
4.9 | 14.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
4.8 | 9.7 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
4.8 | 28.8 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
4.8 | 38.2 | GO:0071625 | vocalization behavior(GO:0071625) |
4.8 | 19.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
4.7 | 14.2 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
4.7 | 28.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
4.7 | 65.9 | GO:0008038 | neuron recognition(GO:0008038) |
4.7 | 14.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.7 | 9.3 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.6 | 27.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
4.6 | 4.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
4.5 | 22.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.5 | 40.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
4.5 | 17.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
4.4 | 35.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
4.4 | 13.2 | GO:0001927 | exocyst assembly(GO:0001927) |
4.3 | 17.3 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
4.3 | 17.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
4.3 | 59.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
4.3 | 12.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
4.2 | 21.1 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
4.2 | 12.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
4.1 | 12.3 | GO:0019042 | viral latency(GO:0019042) |
4.1 | 16.4 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
4.1 | 12.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
4.0 | 52.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
4.0 | 4.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.0 | 20.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
4.0 | 15.8 | GO:0046958 | nonassociative learning(GO:0046958) |
4.0 | 4.0 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
3.9 | 15.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.9 | 11.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
3.9 | 15.5 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
3.9 | 15.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
3.9 | 7.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.9 | 11.6 | GO:0010996 | response to auditory stimulus(GO:0010996) |
3.8 | 11.5 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
3.8 | 46.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.8 | 45.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
3.8 | 18.8 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
3.7 | 7.4 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
3.7 | 3.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
3.7 | 14.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
3.6 | 72.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
3.6 | 18.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.6 | 7.3 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
3.6 | 10.9 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.6 | 25.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
3.6 | 10.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
3.6 | 14.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
3.5 | 7.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
3.5 | 7.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
3.5 | 38.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
3.3 | 6.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
3.3 | 3.3 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
3.3 | 3.3 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
3.3 | 3.3 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
3.3 | 46.0 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
3.3 | 3.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
3.3 | 9.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
3.3 | 9.8 | GO:0097503 | sialylation(GO:0097503) |
3.2 | 13.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
3.2 | 6.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
3.2 | 3.2 | GO:0034650 | cortisol metabolic process(GO:0034650) |
3.2 | 15.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
3.1 | 9.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.1 | 9.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.1 | 18.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
3.1 | 3.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
3.1 | 9.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
3.1 | 15.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
3.1 | 9.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
3.1 | 6.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
3.0 | 3.0 | GO:0021586 | pons maturation(GO:0021586) |
3.0 | 9.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
3.0 | 12.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
3.0 | 8.9 | GO:0051182 | coenzyme transport(GO:0051182) |
3.0 | 14.9 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
3.0 | 23.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
3.0 | 11.9 | GO:0086009 | membrane repolarization(GO:0086009) |
2.9 | 11.7 | GO:0006538 | glutamate catabolic process(GO:0006538) |
2.9 | 41.0 | GO:0001964 | startle response(GO:0001964) |
2.9 | 5.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.9 | 11.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.9 | 8.7 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.9 | 49.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
2.9 | 8.7 | GO:0019086 | late viral transcription(GO:0019086) |
2.9 | 20.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.8 | 11.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
2.8 | 5.6 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
2.8 | 5.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.8 | 22.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
2.8 | 8.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.8 | 125.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.8 | 11.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.8 | 38.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
2.7 | 10.9 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
2.7 | 5.5 | GO:0060166 | olfactory pit development(GO:0060166) |
2.7 | 13.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.6 | 5.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
2.6 | 5.3 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.6 | 18.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.6 | 5.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
2.6 | 7.7 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.6 | 7.7 | GO:0090427 | activation of meiosis(GO:0090427) |
2.5 | 5.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
2.5 | 43.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
2.5 | 5.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.5 | 7.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
2.5 | 7.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.5 | 7.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.5 | 7.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
2.5 | 5.0 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
2.5 | 12.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
2.5 | 7.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
2.5 | 7.4 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
2.5 | 9.8 | GO:0060179 | male mating behavior(GO:0060179) |
2.4 | 7.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
2.4 | 12.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
2.4 | 4.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.4 | 7.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.4 | 7.2 | GO:0021854 | hypothalamus development(GO:0021854) |
2.4 | 9.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
2.4 | 9.5 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
2.3 | 9.3 | GO:0030091 | protein repair(GO:0030091) |
2.3 | 4.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
2.3 | 4.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.3 | 2.3 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
2.3 | 6.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
2.3 | 6.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
2.3 | 2.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.3 | 4.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
2.2 | 9.0 | GO:0060278 | regulation of ovulation(GO:0060278) |
2.2 | 2.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
2.2 | 26.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.2 | 6.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
2.2 | 11.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
2.2 | 6.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.2 | 8.8 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
2.2 | 17.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
2.2 | 8.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.2 | 13.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
2.1 | 10.7 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.1 | 4.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
2.1 | 2.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
2.1 | 10.5 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
2.1 | 6.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.1 | 4.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
2.1 | 2.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
2.1 | 4.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
2.1 | 6.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
2.0 | 4.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
2.0 | 8.1 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
2.0 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.0 | 4.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
2.0 | 10.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
2.0 | 6.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
2.0 | 4.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.0 | 2.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
2.0 | 2.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
2.0 | 19.7 | GO:0060736 | prostate gland growth(GO:0060736) |
2.0 | 29.3 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.9 | 5.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.9 | 3.9 | GO:0099612 | protein localization to axon(GO:0099612) |
1.9 | 7.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
1.9 | 3.9 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
1.9 | 5.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.9 | 3.8 | GO:0060594 | mammary gland specification(GO:0060594) |
1.9 | 3.8 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.9 | 7.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.9 | 13.4 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.9 | 1.9 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.9 | 9.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.9 | 11.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.9 | 9.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.9 | 3.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.9 | 5.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
1.9 | 24.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
1.9 | 11.3 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.9 | 5.6 | GO:0008355 | olfactory learning(GO:0008355) |
1.9 | 7.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
1.9 | 13.1 | GO:0006108 | malate metabolic process(GO:0006108) |
1.9 | 14.9 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
1.9 | 3.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.8 | 3.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
1.8 | 12.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.8 | 5.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.8 | 9.2 | GO:0048242 | epinephrine secretion(GO:0048242) |
1.8 | 5.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.8 | 3.7 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
1.8 | 7.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
1.8 | 9.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.8 | 5.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.8 | 7.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.8 | 3.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.8 | 16.3 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.8 | 14.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.8 | 16.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.8 | 3.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.8 | 12.6 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.8 | 109.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.8 | 1.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.8 | 5.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.8 | 3.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.8 | 8.8 | GO:0008354 | germ cell migration(GO:0008354) |
1.7 | 10.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.7 | 1.7 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
1.7 | 6.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.7 | 3.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.7 | 1.7 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
1.7 | 10.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
1.7 | 1.7 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
1.7 | 3.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.7 | 6.9 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.7 | 5.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.7 | 8.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.7 | 10.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.7 | 15.3 | GO:0060384 | innervation(GO:0060384) |
1.7 | 5.1 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.7 | 5.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.7 | 1.7 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.7 | 3.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.7 | 3.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.7 | 1.7 | GO:0009750 | response to fructose(GO:0009750) |
1.7 | 8.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
1.7 | 6.7 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
1.6 | 1.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
1.6 | 4.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.6 | 1.6 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.6 | 1.6 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.6 | 3.2 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
1.6 | 1.6 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.6 | 3.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
1.6 | 6.4 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.6 | 4.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.6 | 3.2 | GO:0021554 | optic nerve development(GO:0021554) |
1.6 | 7.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.6 | 1.6 | GO:0034331 | cell junction maintenance(GO:0034331) |
1.6 | 1.6 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.6 | 1.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.6 | 29.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
1.6 | 3.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.6 | 6.2 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
1.6 | 7.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.6 | 1.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.5 | 4.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.5 | 3.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
1.5 | 1.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
1.5 | 1.5 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.5 | 3.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.5 | 9.2 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
1.5 | 3.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.5 | 3.0 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
1.5 | 1.5 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
1.5 | 1.5 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
1.5 | 7.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.5 | 14.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.5 | 5.9 | GO:0034776 | response to histamine(GO:0034776) |
1.5 | 3.0 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.5 | 5.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.5 | 10.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.5 | 4.4 | GO:0070305 | response to cGMP(GO:0070305) |
1.5 | 8.8 | GO:0015824 | proline transport(GO:0015824) |
1.5 | 4.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
1.5 | 2.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.5 | 4.4 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.5 | 2.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.4 | 5.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.4 | 4.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
1.4 | 5.8 | GO:0051697 | protein delipidation(GO:0051697) |
1.4 | 4.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.4 | 2.8 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.4 | 1.4 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.4 | 5.5 | GO:0035627 | ceramide transport(GO:0035627) |
1.4 | 4.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.4 | 6.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.4 | 2.8 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
1.4 | 8.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
1.4 | 1.4 | GO:0061055 | myotome development(GO:0061055) |
1.4 | 8.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.4 | 2.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.4 | 2.7 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.4 | 8.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.3 | 4.0 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
1.3 | 4.0 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
1.3 | 4.0 | GO:0015747 | urate transport(GO:0015747) |
1.3 | 14.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
1.3 | 2.7 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.3 | 6.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.3 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 7.9 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.3 | 2.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
1.3 | 1.3 | GO:0015846 | polyamine transport(GO:0015846) |
1.3 | 3.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
1.3 | 3.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.3 | 1.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.3 | 6.5 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
1.3 | 2.6 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
1.3 | 3.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
1.3 | 5.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.3 | 10.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.3 | 15.4 | GO:0021511 | spinal cord patterning(GO:0021511) |
1.3 | 5.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
1.3 | 9.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.3 | 1.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 11.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.3 | 6.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 8.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.3 | 3.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.3 | 1.3 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.3 | 1.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.3 | 2.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
1.3 | 17.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
1.2 | 3.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
1.2 | 5.0 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.2 | 9.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
1.2 | 6.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
1.2 | 7.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
1.2 | 1.2 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
1.2 | 2.4 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
1.2 | 6.1 | GO:0030432 | peristalsis(GO:0030432) |
1.2 | 2.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
1.2 | 3.7 | GO:0002254 | kinin cascade(GO:0002254) |
1.2 | 2.4 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
1.2 | 2.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.2 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.2 | 4.8 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
1.2 | 22.8 | GO:0019228 | neuronal action potential(GO:0019228) |
1.2 | 2.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.2 | 2.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.2 | 4.7 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.2 | 1.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.2 | 9.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.2 | 4.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.2 | 3.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 5.9 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.2 | 22.2 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
1.2 | 3.5 | GO:0060437 | lung growth(GO:0060437) |
1.2 | 9.3 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.2 | 2.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.2 | 3.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.2 | 8.1 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.2 | 5.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.1 | 3.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.1 | 3.4 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.1 | 11.5 | GO:0098926 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.1 | 3.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
1.1 | 4.6 | GO:0048263 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
1.1 | 2.3 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.1 | 2.3 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.1 | 3.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
1.1 | 3.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.1 | 9.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.1 | 6.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.1 | 2.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.1 | 3.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
1.1 | 3.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
1.1 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 2.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
1.1 | 3.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.1 | 3.3 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 13.2 | GO:0034389 | lipid particle organization(GO:0034389) |
1.1 | 3.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 74.7 | GO:0007612 | learning(GO:0007612) |
1.1 | 1.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
1.1 | 1.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.1 | 5.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.1 | 1.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.1 | 17.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.1 | 3.2 | GO:0036233 | glycine import(GO:0036233) |
1.1 | 3.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
1.1 | 4.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.1 | 1.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
1.0 | 3.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
1.0 | 5.2 | GO:0060004 | reflex(GO:0060004) |
1.0 | 2.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 17.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.0 | 7.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 3.0 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
1.0 | 1.0 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
1.0 | 1.0 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
1.0 | 4.0 | GO:0033227 | dsRNA transport(GO:0033227) |
1.0 | 7.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
1.0 | 8.0 | GO:0060914 | heart formation(GO:0060914) |
1.0 | 2.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.0 | 2.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
1.0 | 4.0 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.0 | 2.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.0 | 8.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
1.0 | 4.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.0 | 8.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
1.0 | 2.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.0 | 1.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
1.0 | 1.0 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
1.0 | 3.9 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
1.0 | 6.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
1.0 | 1.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.0 | 7.7 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.0 | 1.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.0 | 1.0 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.0 | 2.9 | GO:0032570 | response to progesterone(GO:0032570) |
1.0 | 8.7 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
1.0 | 1.9 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
1.0 | 6.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.0 | 11.4 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.9 | 0.9 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.9 | 1.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.9 | 1.9 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.9 | 2.8 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.9 | 0.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.9 | 1.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 3.7 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.9 | 1.8 | GO:0030576 | Cajal body organization(GO:0030576) |
0.9 | 3.7 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.9 | 5.5 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.9 | 2.7 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.9 | 2.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.9 | 2.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.9 | 3.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.9 | 0.9 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.9 | 8.0 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.9 | 2.7 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.9 | 3.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.9 | 1.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.9 | 2.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.9 | 1.7 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.9 | 1.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.9 | 5.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.9 | 6.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.9 | 1.7 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.9 | 5.1 | GO:0007135 | meiosis II(GO:0007135) |
0.8 | 5.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.8 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 2.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.8 | 2.5 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.8 | 3.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.8 | 1.7 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.8 | 0.8 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.8 | 81.7 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.8 | 6.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.8 | 3.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.8 | 1.6 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.8 | 1.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 1.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.8 | 3.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.8 | 4.0 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 2.4 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.8 | 3.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.8 | 3.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.8 | 3.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.8 | 1.6 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 11.0 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.8 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.8 | 1.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 3.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.8 | 3.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.8 | 1.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.8 | 1.5 | GO:0090135 | actin filament branching(GO:0090135) |
0.7 | 9.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.7 | 2.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 2.2 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.7 | 0.7 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 2.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.7 | 3.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.7 | 3.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.7 | 0.7 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.7 | 15.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.7 | 1.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 0.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 32.5 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.7 | 1.4 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.7 | 0.7 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.7 | 6.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.7 | 1.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.7 | 1.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.7 | 3.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.7 | 2.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.7 | 2.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.7 | 3.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.7 | 2.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.7 | 0.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.7 | 0.7 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.7 | 2.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.7 | 1.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.7 | 4.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.7 | 8.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.7 | 1.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.7 | 1.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.7 | 0.7 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.7 | 4.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 3.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 1.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.7 | 2.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 2.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.7 | 9.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 1.3 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.7 | 0.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.7 | 0.7 | GO:0019230 | proprioception(GO:0019230) |
0.7 | 3.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 0.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 3.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.7 | 15.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.6 | 5.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.6 | 1.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.6 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 4.5 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.6 | 3.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.6 | 0.6 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.6 | 1.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.6 | 1.3 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 1.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.6 | 5.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.6 | 3.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.6 | 1.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.6 | 0.6 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.6 | 1.9 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.6 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 0.6 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.6 | 2.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.6 | 1.8 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 1.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.6 | 1.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.6 | 5.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.6 | 18.6 | GO:0046847 | filopodium assembly(GO:0046847) |
0.6 | 1.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.6 | 2.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 0.6 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.6 | 3.6 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) positive regulation of macrophage cytokine production(GO:0060907) |
0.6 | 3.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.6 | 0.6 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.6 | 1.8 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 0.6 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.6 | 7.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.6 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.6 | 3.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 7.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.6 | 2.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.6 | 2.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.6 | 2.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.6 | 1.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.6 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 1.1 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.6 | 2.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.6 | 0.6 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.6 | 0.6 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.6 | 0.6 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.6 | 1.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.6 | 1.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.6 | 3.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 0.6 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.6 | 3.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.6 | 0.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 1.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.5 | 11.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.5 | 2.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 3.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.5 | 6.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 1.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 3.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.5 | 2.7 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.5 | 2.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 0.5 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 0.5 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.5 | 0.5 | GO:0002339 | B cell selection(GO:0002339) |
0.5 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 4.2 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.5 | 1.0 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 1.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.5 | 3.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.5 | 0.5 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.5 | 4.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.5 | 2.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 1.0 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.5 | 1.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 1.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 2.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.5 | 1.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.5 | 1.5 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.5 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
0.5 | 0.5 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.5 | 0.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.5 | 2.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 1.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 0.5 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.5 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 1.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 2.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.5 | 0.5 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.5 | 1.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.5 | 4.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.4 | 2.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 0.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 0.9 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.4 | 1.8 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.4 | 0.9 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 0.9 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.4 | 0.4 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.4 | 0.9 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.4 | 2.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 0.9 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.4 | 7.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 1.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 1.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.4 | 5.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.4 | 2.5 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.4 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 3.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 1.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 1.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.4 | 2.8 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.4 | 1.2 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.4 | 0.8 | GO:0015755 | fructose transport(GO:0015755) |
0.4 | 0.4 | GO:0072044 | collecting duct development(GO:0072044) |
0.4 | 5.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.4 | 0.4 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.4 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.4 | 1.9 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 0.4 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 1.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 0.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.4 | 1.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 1.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.4 | 1.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.4 | 1.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 3.3 | GO:0045056 | transcytosis(GO:0045056) |
0.4 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 1.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 2.1 | GO:0090382 | phagosome maturation(GO:0090382) |
0.3 | 3.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 0.7 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 0.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.3 | 1.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.3 | 3.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 5.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.3 | 3.5 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.3 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 4.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 1.9 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.3 | 5.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 1.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 3.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.3 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.3 | 0.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.3 | 2.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.3 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.3 | 0.6 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 6.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.3 | 5.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.3 | 0.3 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 0.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.3 | 0.6 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.3 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.3 | 0.9 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 0.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 5.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 1.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.3 | 0.3 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 0.8 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.8 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.5 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.3 | 0.5 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.2 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.2 | 1.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 1.6 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 0.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 1.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 3.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 1.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.5 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.2 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 10.9 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 0.2 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.2 | 0.2 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.2 | 1.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.6 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.2 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.7 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.5 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 0.7 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 3.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 0.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.2 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.2 | GO:0090238 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.2 | 0.7 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.2 | 2.9 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.2 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 0.2 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.2 | 0.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.8 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0015817 | glutamine transport(GO:0006868) histidine transport(GO:0015817) |
0.1 | 0.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 2.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 2.8 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 2.0 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.8 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 1.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 4.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.8 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.3 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.8 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 2.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.2 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 0.1 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.1 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 3.1 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.8 | GO:1904874 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.1 | 0.7 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.3 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 0.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.1 | 0.1 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.0 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:1905209 | positive regulation of cardiocyte differentiation(GO:1905209) |
0.0 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.2 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.0 | 0.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 34.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
9.6 | 28.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
7.2 | 65.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
7.1 | 50.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
6.9 | 69.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
6.3 | 25.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
5.9 | 29.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.8 | 69.1 | GO:0043194 | axon initial segment(GO:0043194) |
5.5 | 27.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
5.4 | 21.5 | GO:0043198 | dendritic shaft(GO:0043198) |
5.4 | 32.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.9 | 68.7 | GO:0030673 | axolemma(GO:0030673) |
4.8 | 14.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
4.6 | 36.6 | GO:0043083 | synaptic cleft(GO:0043083) |
4.6 | 9.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
4.5 | 26.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
4.4 | 117.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
4.3 | 34.5 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.3 | 12.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
4.1 | 16.4 | GO:1990696 | USH2 complex(GO:1990696) |
3.9 | 23.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
3.9 | 11.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
3.8 | 103.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
3.8 | 15.3 | GO:0032021 | NELF complex(GO:0032021) |
3.7 | 119.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
3.7 | 14.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.5 | 14.0 | GO:0044308 | axonal spine(GO:0044308) |
3.5 | 24.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
3.3 | 10.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.3 | 6.6 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
3.1 | 33.6 | GO:0032433 | filopodium tip(GO:0032433) |
3.0 | 8.9 | GO:0033269 | internode region of axon(GO:0033269) |
2.8 | 65.5 | GO:0044295 | axonal growth cone(GO:0044295) |
2.8 | 8.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.7 | 8.2 | GO:0072534 | perineuronal net(GO:0072534) |
2.7 | 18.8 | GO:0032584 | growth cone membrane(GO:0032584) |
2.7 | 13.4 | GO:0070695 | FHF complex(GO:0070695) |
2.7 | 5.3 | GO:0033263 | CORVET complex(GO:0033263) |
2.6 | 42.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
2.6 | 5.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.6 | 15.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
2.6 | 2.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.5 | 12.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.4 | 14.6 | GO:0071437 | invadopodium(GO:0071437) |
2.4 | 53.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.4 | 4.7 | GO:0097441 | basilar dendrite(GO:0097441) |
2.4 | 32.9 | GO:0031045 | dense core granule(GO:0031045) |
2.3 | 7.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.3 | 32.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
2.2 | 6.7 | GO:0000322 | storage vacuole(GO:0000322) |
2.2 | 22.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
2.2 | 319.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
2.1 | 6.4 | GO:0043511 | inhibin complex(GO:0043511) |
2.1 | 10.5 | GO:0000235 | astral microtubule(GO:0000235) |
2.1 | 8.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.1 | 6.2 | GO:0042583 | chromaffin granule(GO:0042583) |
2.1 | 211.1 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
2.1 | 20.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.1 | 10.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.0 | 22.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
2.0 | 24.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
2.0 | 8.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.9 | 9.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.9 | 25.2 | GO:0034704 | calcium channel complex(GO:0034704) |
1.8 | 7.3 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.8 | 5.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.7 | 86.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.7 | 18.7 | GO:0060076 | excitatory synapse(GO:0060076) |
1.7 | 5.0 | GO:0033010 | paranodal junction(GO:0033010) |
1.6 | 11.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.6 | 14.6 | GO:0000124 | SAGA complex(GO:0000124) |
1.6 | 6.4 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
1.6 | 12.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.6 | 14.3 | GO:0005869 | dynactin complex(GO:0005869) |
1.6 | 4.7 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.6 | 6.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.6 | 4.7 | GO:0070552 | BRISC complex(GO:0070552) |
1.6 | 6.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
1.5 | 8.9 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
1.5 | 4.5 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
1.5 | 8.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.4 | 4.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
1.4 | 2.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.4 | 12.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.4 | 5.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.3 | 6.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.3 | 6.7 | GO:0005915 | zonula adherens(GO:0005915) |
1.3 | 4.0 | GO:0097449 | astrocyte projection(GO:0097449) |
1.3 | 1.3 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
1.3 | 4.0 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.3 | 5.2 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.3 | 2.6 | GO:0071203 | WASH complex(GO:0071203) |
1.3 | 6.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.3 | 3.8 | GO:0071942 | XPC complex(GO:0071942) |
1.2 | 3.7 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
1.2 | 3.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.2 | 12.3 | GO:0097440 | apical dendrite(GO:0097440) |
1.2 | 9.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
1.2 | 3.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.2 | 6.0 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.2 | 43.6 | GO:0030175 | filopodium(GO:0030175) |
1.2 | 12.9 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 10.0 | GO:0036156 | inner dynein arm(GO:0036156) |
1.1 | 7.7 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
1.1 | 11.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
1.1 | 70.9 | GO:0030426 | growth cone(GO:0030426) |
1.0 | 5.2 | GO:0097433 | dense body(GO:0097433) |
1.0 | 5.0 | GO:0061617 | MICOS complex(GO:0061617) |
1.0 | 3.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.0 | 2.9 | GO:0097427 | microtubule bundle(GO:0097427) |
1.0 | 2.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 16.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.9 | 2.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 3.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.9 | 30.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.9 | 55.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.9 | 5.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.9 | 6.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.9 | 7.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 2.6 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.9 | 10.4 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.9 | 2.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.9 | 6.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.8 | 2.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.8 | 2.5 | GO:0036396 | MIS complex(GO:0036396) |
0.8 | 12.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.8 | 3.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.8 | 1.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.8 | 4.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.8 | 20.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.7 | 49.0 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 3.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 99.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.7 | 2.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.7 | 2.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.7 | 4.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.7 | 47.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.7 | 2.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.7 | 2.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.7 | 2.6 | GO:0035339 | SPOTS complex(GO:0035339) |
0.6 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 9.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 24.9 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.6 | 10.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.6 | 5.4 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 2.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 15.4 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 1.5 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.5 | 1.9 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.5 | 8.9 | GO:0005686 | U2 snRNP(GO:0005686) |
0.5 | 2.3 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 1.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 4.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
0.4 | 86.4 | GO:0045202 | synapse(GO:0045202) |
0.4 | 0.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 0.4 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.4 | 2.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.4 | 1.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 4.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.4 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.4 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 2.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.3 | 1.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 3.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.3 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 2.9 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 2.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 3.5 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 1.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 2.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 8.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 0.7 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.1 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.6 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.4 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.1 | 1.4 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 2.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 1.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.3 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.7 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.2 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
21.7 | 65.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
14.6 | 43.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.9 | 59.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
11.3 | 33.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
10.0 | 29.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
9.5 | 28.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
8.5 | 25.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
8.3 | 8.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
7.7 | 30.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
7.2 | 28.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
7.0 | 28.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
7.0 | 20.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
6.8 | 41.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
6.6 | 33.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
6.4 | 19.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.3 | 18.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
6.1 | 66.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
5.8 | 29.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
5.3 | 21.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
5.3 | 5.3 | GO:0055100 | adiponectin binding(GO:0055100) |
5.3 | 15.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
5.3 | 15.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
5.2 | 10.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
5.1 | 25.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
4.9 | 19.6 | GO:0097001 | ceramide binding(GO:0097001) |
4.5 | 18.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.5 | 17.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
4.3 | 8.6 | GO:0097016 | L27 domain binding(GO:0097016) |
4.3 | 25.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.3 | 21.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
4.3 | 4.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
4.2 | 84.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
4.2 | 21.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
4.2 | 16.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
4.0 | 32.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
4.0 | 8.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.0 | 11.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
3.8 | 52.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
3.7 | 18.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
3.7 | 44.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
3.7 | 7.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
3.6 | 21.3 | GO:0048495 | Roundabout binding(GO:0048495) |
3.5 | 10.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
3.5 | 14.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.5 | 6.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
3.5 | 13.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
3.4 | 13.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
3.4 | 23.6 | GO:0003680 | AT DNA binding(GO:0003680) |
3.4 | 10.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.4 | 13.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.3 | 6.6 | GO:0051425 | PTB domain binding(GO:0051425) |
3.1 | 12.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.1 | 98.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
3.1 | 9.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.0 | 38.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
3.0 | 14.8 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.9 | 8.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.9 | 8.8 | GO:0043398 | HLH domain binding(GO:0043398) |
2.9 | 8.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.8 | 27.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.7 | 19.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.7 | 10.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.7 | 13.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
2.6 | 2.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.6 | 7.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.6 | 7.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.6 | 7.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.5 | 12.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
2.5 | 74.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
2.5 | 12.4 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
2.5 | 7.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.5 | 7.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.4 | 7.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.4 | 9.5 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
2.4 | 19.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.4 | 21.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
2.4 | 14.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.3 | 4.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.3 | 7.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.3 | 20.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
2.3 | 9.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.3 | 16.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.3 | 27.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.2 | 11.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.2 | 35.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
2.2 | 8.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.2 | 6.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
2.2 | 6.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
2.1 | 40.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.1 | 18.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
2.1 | 8.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
2.1 | 20.8 | GO:0051378 | serotonin binding(GO:0051378) |
2.1 | 6.2 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
2.1 | 6.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.1 | 6.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
2.0 | 6.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.0 | 6.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
2.0 | 2.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.0 | 25.4 | GO:0030955 | potassium ion binding(GO:0030955) |
1.9 | 54.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
1.9 | 9.6 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.9 | 13.4 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.9 | 15.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.9 | 17.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.9 | 7.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.9 | 7.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
1.9 | 22.3 | GO:0031005 | filamin binding(GO:0031005) |
1.8 | 3.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.8 | 3.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.8 | 60.6 | GO:0019894 | kinesin binding(GO:0019894) |
1.8 | 3.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.8 | 5.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.8 | 21.9 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.8 | 7.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.8 | 19.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.8 | 5.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.8 | 38.6 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.7 | 7.0 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
1.7 | 46.7 | GO:0030507 | spectrin binding(GO:0030507) |
1.7 | 6.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.7 | 5.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
1.7 | 5.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
1.7 | 10.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.7 | 6.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.7 | 8.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.6 | 11.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.6 | 3.2 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
1.6 | 6.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.6 | 4.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.6 | 17.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.6 | 7.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.6 | 4.7 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
1.5 | 6.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
1.5 | 7.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.5 | 1.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.5 | 4.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.5 | 20.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.5 | 3.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.5 | 4.5 | GO:2001069 | glycogen binding(GO:2001069) |
1.4 | 5.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.4 | 8.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
1.4 | 8.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.4 | 7.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.4 | 1.4 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.4 | 5.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.4 | 6.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.4 | 13.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.4 | 8.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.4 | 4.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.4 | 34.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.4 | 13.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 14.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.3 | 3.9 | GO:0018598 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
1.3 | 2.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
1.3 | 2.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.3 | 5.2 | GO:1990254 | keratin filament binding(GO:1990254) |
1.3 | 26.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
1.3 | 5.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.2 | 6.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.2 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.2 | 7.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.2 | 3.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.2 | 5.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.2 | 5.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.2 | 1.2 | GO:0038191 | neuropilin binding(GO:0038191) |
1.2 | 3.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.2 | 3.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
1.2 | 2.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.1 | 11.5 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
1.1 | 9.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.1 | 26.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.1 | 10.0 | GO:0018855 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.1 | 14.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 54.0 | GO:0017022 | myosin binding(GO:0017022) |
1.1 | 16.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.1 | 4.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.1 | 21.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.1 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.1 | 2.1 | GO:0070840 | dynein complex binding(GO:0070840) |
1.0 | 3.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.0 | 1.0 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
1.0 | 2.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.0 | 7.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.0 | 2.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.0 | 2.9 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.0 | 10.6 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
1.0 | 2.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.0 | 3.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.9 | 9.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 4.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 11.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.9 | 2.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.9 | 47.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.9 | 12.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.9 | 0.9 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 2.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.9 | 1.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.9 | 6.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.9 | 5.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.9 | 4.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.9 | 4.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.9 | 35.3 | GO:0030276 | clathrin binding(GO:0030276) |
0.9 | 7.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.9 | 6.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.8 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.8 | 0.8 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.8 | 5.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.8 | 3.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.8 | 5.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.8 | 2.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.8 | 20.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.8 | 2.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 8.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 2.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 3.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 4.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.8 | 4.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 2.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.8 | 4.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.8 | 7.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.8 | 16.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.8 | 1.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.8 | 2.3 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 3.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.8 | 3.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.8 | 20.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.8 | 3.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.8 | 5.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.7 | 2.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 1.5 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.7 | 20.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.7 | 7.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.7 | 4.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.7 | 3.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 14.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.7 | 14.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.7 | 7.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.7 | 3.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.7 | 8.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.7 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 2.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.6 | 1.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 4.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 2.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 2.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 1.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 2.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 0.6 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 3.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 3.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 5.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.6 | 8.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 12.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.6 | 8.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.6 | 1.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.6 | 11.8 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 5.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.6 | 19.4 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.6 | 2.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.6 | 1.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.6 | 2.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.5 | 6.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 3.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 5.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.5 | 2.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.5 | 5.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.5 | 5.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 4.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.5 | 18.6 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.5 | 5.0 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 1.0 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.5 | 0.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.5 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 1.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.5 | 15.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.5 | 5.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 0.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.5 | 4.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 3.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.5 | 18.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.5 | 15.7 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.5 | 2.7 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.5 | 1.8 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.4 | 9.3 | GO:0005267 | potassium channel activity(GO:0005267) |
0.4 | 12.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 0.8 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.4 | 1.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 7.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 0.8 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.4 | 0.4 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.4 | 8.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 1.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 1.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.4 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 2.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 1.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 6.4 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.3 | 3.0 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 4.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 2.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 1.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 5.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.3 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.3 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.2 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 0.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 0.6 | GO:0015925 | galactosidase activity(GO:0015925) |
0.3 | 2.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 3.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 3.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.3 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 4.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 2.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 3.6 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.2 | 0.2 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.7 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.2 | 2.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 1.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.9 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 6.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.2 | 20.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 1.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 2.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 8.3 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 6.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 1.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 0.4 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 2.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 67.7 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 3.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 1.1 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.4 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 2.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 6.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.5 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.3 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.1 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 6.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 11.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 4.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.9 | 94.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.0 | 52.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.7 | 5.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.3 | 16.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.3 | 42.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
1.2 | 10.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 7.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.1 | 25.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 14.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 43.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.9 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.8 | 2.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.7 | 4.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 7.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 16.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 1.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.6 | 3.9 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 11.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.6 | 18.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 6.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 1.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 11.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.6 | 3.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 9.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.5 | 8.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 6.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.5 | 2.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 2.9 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 3.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 4.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 5.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 5.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 0.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 5.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 4.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 1.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 47.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 1.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 94.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
5.8 | 11.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
5.4 | 59.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.9 | 39.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.9 | 11.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
3.8 | 57.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.5 | 42.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.4 | 37.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.3 | 141.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.9 | 5.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
2.9 | 54.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.8 | 71.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
2.8 | 44.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
2.5 | 56.1 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
2.5 | 30.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
2.5 | 36.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.4 | 17.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.4 | 19.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
2.4 | 33.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.3 | 4.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
2.2 | 2.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
2.1 | 49.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.1 | 70.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
2.1 | 27.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
2.1 | 28.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
2.0 | 22.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
2.0 | 10.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.7 | 1.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.7 | 1.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
1.6 | 17.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.6 | 8.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
1.5 | 1.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.5 | 1.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.5 | 16.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.5 | 18.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.4 | 26.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 15.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.2 | 14.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.2 | 12.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.1 | 29.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.0 | 21.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.0 | 12.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.0 | 14.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.0 | 2.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.0 | 1.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.0 | 11.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.9 | 5.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.9 | 9.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.9 | 17.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.9 | 30.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.9 | 16.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.8 | 5.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.8 | 7.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.8 | 51.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.8 | 3.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 3.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.7 | 5.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 13.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.7 | 5.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 10.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.6 | 7.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 22.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.6 | 4.4 | REACTOME OPSINS | Genes involved in Opsins |
0.6 | 7.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 11.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.6 | 6.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 12.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.6 | 1.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.6 | 4.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.6 | 6.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 5.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.5 | 6.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.5 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 0.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.5 | 3.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.5 | 8.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 4.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 7.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 3.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.4 | 6.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 6.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 1.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.4 | 3.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 7.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 1.4 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.4 | 6.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 2.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 7.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 2.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 2.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.3 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 6.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 0.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 1.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 2.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 4.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 3.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 8.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 3.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 2.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 15.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 3.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 6.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 0.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 3.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |